Monday, 26 August 2013

Neuropathy: FaceBook Chat August 28th

Today's post comes from the Neuropathy Association via (see link below) and is a notification of another FaceBook Chat about neuropathy, taking place in a couple of days time (28/8/2013). This one could be especially useful for those living with neuropathy in their lives, both patients and those around them. If you don't have Facebook, there is a link at the end of the post showing how you can still follow the 'chat' live via the Neuropathy Association Facebook page itself.



August 28, 2013 @ 4:00 pm – 5:30 pm




Neuropathy Association
Event website

We are excited to announce that Drs. Jaydeep Bhatt, Myrna Cardiel, and William Schwieterman will be hosting a “chat” event on The Neuropathy Association’s Facebook page on August 28th aimed at helping us better understand how neuropathy affects us—from head to toe.

FACEBOOK CHAT: “There’s More To Neuropathy Than Numbness, Weakness, Tingling, and Pain”


WHEN: August 28th, 2013 (7pm – 8:30pm ET)

GUEST HOSTS: Dr. Jaydeep Bhatt (NYU); Dr. Myrna Cardiel (NYU); and Dr. William D. Schwieterman (Chelsea Therapeutics)

WHO SHOULD PARTICIPATE: Patients, family members, friends, health care professionals, and caregivers

Ongoing education, communication, and support are important tools to work with when neuropathy affects both you and your loved ones. Using these tools improves a family’s ability to work together to manage the day-to-day aspects of living with a chronic disease like neuropathy.From head to toe, every part of the human body contains peripheral nerves. So, peripheral neuropathy can be a “whole body” experience, involving a range of symptoms that you may — or may not — recognize as part of your neuropathy. Neuropathy’s symptoms vary depending on where the nerve damage is occurring in the body. It also varies depending on what type of peripheral nerves — motor, sensory, and autonomic that connect the spinal cord to the muscles, skin, blood vessels, and internal organs — are involved.

Drs. Bhatt, Cardiel, and Schwieterman will field questions posed by the Chat participants while also discussing the importance of recognizing the varying symptoms of neuropathy. The Chats offer participants a chance to hear from and ask questions of their peers—patients and caregivers—who are battling neuropathy. The Chats also emphasize that living well with neuropathy is possible with early diagnosis, symptom management, and regular follow-ups, but it requires active engagement by the patient in his/her own medical care along with the aid of an array of resources—limited as they are—that do currently exist.

Dr. Jaydeep Bhatt is an assistant professor of Neurology at New York University School of Medicine. Dr. Bhatt is board certified in Neurology and Electrodiagnostic Medicine and has a clinical and academic subspecialty in neuromuscular disorders including peripheral and entrapment neuropathies, myopathies, motor neuron disease, and myasthenia gravis.

Dr. Myrna Cardiel is a clinical assistant professor of Neurology at New York University School of Medicine. Dr. Cardiel completed a clinical neurophysiology fellowship at NYU. Previously, she practiced general neurology while on active military service in the United States Army, where she held the rank of Major. Dr. Cardiel completed her internship and residency training in neurology at Walter Reed Army Medical Center, the National Naval Medical Center, and the Uniformed Services University of the Health Sciences. She is board certified in Neurology and Electrodiagnostic Medicine.

Dr. William D. Schwieterman is Chief Medical Officer at Chelsea Therapeutics. Chelsea Therapeutics is a development stage biopharmaceutical company located in Charlotte, North Carolina. Chelsea is currently pursuing FDA approval in the U.S. for Northera™ (droxidopa), a novel, late-stage, orally-active therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension resulting from various neurodegenerative diseases, including Parkinson’s disease, multiple system atrophy and pure autonomic failure. After graduating from the University of Cincinnati College of Medicine and completing his residency in Internal Medicine at Mt Sinai Hospital and fellowship in rheumatology at the National Institutes of Arthritis and Musculoskeletal Skin Disease (NIAMS), Dr. Schwieterman joined the Food and Drug Administration’s (FDA) Center for Biologics, where he reviewed and supervised the development of numerous investigational biotech agents for the development of a wide range of diseases.

We look forward to having you join us on August 28th for this Facebook Chat. A special thanks to Drs. Bhatt, Cardiel, and Schwieterman for giving their time and expertise to speak with our community!

Wishing you good health,

The Neuropathy Association

P.S. If you do not use Facebook:

- You can still access the Chat “live” by visiting The Neuropathy Association’s Facebook page, but you will not be able to join the conversation by posting comments.
View the Association’s Facebook page!

No comments:

Post a Comment

All comments welcome but advertising your own service or product will unfortunately result in your comment not being published.